97841004
Mar 15, 2023
Acellular therapeutic agents for use in treating primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), ovarian cancer, lung cancer, and breast cancer; Oncology therapeutic agents and diagnostics reagents for medical use; Extracellular vesicles diagnostic reagents for medical use and therapeutic agents for use in treating ovarian cancer, breast cancer, and lung cancer; Neurology diagnostic reagents for medical use and therapeutic agents for use in neurological treatments
Pharmaceuticals